Mode of action of ticagrelor at the human platelet P2Y12-receptor

被引：0
|
作者：
Hoffmann, K. [1 ]
von Kuegelgen, I [1 ]
机构：
[1] Univ Bonn, Inst Pharmakol & Toxikol, D-53127 Bonn, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2013年 / 386卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
138
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease
    Iring, Andras
    Toth, Adrian
    Baranyi, Maria
    Otrokocsi, Lilla
    Modis, Laszlo
    Goloncser, Flora
    Iring-Varga, Bernadett
    Hortobagyi, Tibor
    Bereczki, Daniel
    Denes, Adam
    Sperlagh, Ms Beata
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 984 - 984
  • [42] The Function and Regulation of Platelet P2Y12 Receptor
    Xiaohua Li
    Guoxing Zhang
    Xia Cao
    Cardiovascular Drugs and Therapy, 2023, 37 : 199 - 216
  • [43] The Function and Regulation of Platelet P2Y12 Receptor
    Li, Xiaohua
    Zhang, Guoxing
    Cao, Xia
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (01) : 199 - 216
  • [44] Biology and pharmacology of the platelet P2Y12 receptor
    Storey, Robert F.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (10) : 1255 - 1259
  • [45] Insights into platelet P2Y12 receptor activation
    Nicholas, Robert A.
    BLOOD, 2015, 125 (06) : 893 - 895
  • [46] Antiplatelet effects of oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor
    Hochholzer, W.
    Stratz, C.
    Kleiner, P.
    Younas, I.
    Valina, C. M.
    Loeffelhardt, N.
    Amann, M.
    Ferenc, M.
    Trenk, D.
    Neumann, F. J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 645 - 645
  • [47] Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
    Aungraheeta, Riyaad
    Conibear, Alexandra
    Butler, Mark
    Kelly, Eamonn
    Nylander, Sven
    Mumford, Andrew
    Mundell, Stuart J.
    BLOOD, 2016, 128 (23) : 2717 - 2728
  • [48] Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
    Becker, Richard C.
    Bassand, Jean Pierre
    Budaj, Andrzej
    Wojdyla, Daniel M.
    James, Stefan K.
    Cornel, Jan H.
    French, John
    Held, Claes
    Horrow, Jay
    Husted, Steen
    Lopez-Sendon, Jose
    Lassila, Riitta
    Mahaffey, Kenneth W.
    Storey, Robert F.
    Harrington, Robert A.
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2011, 32 (23) : 2933 - 2944
  • [49] No effect of platelet supplementation to reverse the P2Y12 inhibitor ticagrelor: an in vitro study
    Martin, A-C
    Berndt, C.
    Gaussem, P.
    Gouin-Thibault, I
    Siguret, V
    Le Bonniec, B.
    Bachelot-Loza, C.
    Godier, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 16 - 17
  • [50] No effect of platelet supplementation to reverse the P2Y12 inhibitor ticagrelor: an in vitro study
    Martin, A. -C.
    Berndt, C.
    Gaussem, P.
    Gouin-Thibault, I.
    Siguret, V.
    Le Bonniec, B.
    Godier, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1170 - 1170
12345